Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Uncover ways to enhance credit card points accumulation and earn more rewards. Follow these tips for a more fruitful rewards journey.
17,849 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Kettle Hill Capital Management disclosed a new stake in RH, loading about 161,122 shares worth roughly $28.9 million....
EURC’s record network growth has pushed on-chain activity to multi-year highs, underscoring a shift in Europe toward ...
Advanced Micro Devices stock dropped sharply last month as tech valuations cooled. This guide breaks down the drivers...
Fermentation is moving from kitchen experiments to a mainstream personal-finance story, even as questions linger abou...
Barrick mining stock sinking this week is a reminder that miners ride metal prices as much as earnings. Here’s what’s...
Oklo faced a sharp pullback in early 2026 as sector bets cooled and financing moves pressured shares. This guide brea...
This week brought a sharp pullback in precious metals equities. We break down what drove the move, how it affects New...
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...
A new market dynamic shows Bitcoin ETF assets can shrink without investors selling, as mark-to-market losses mute the...
A high-profile death prompts the release of the medical examiner’s early findings detailing an aortic rupture. Invest...
NuScale Power faced a sharp February sell-off as project delays, funding needs, and analyst downgrades weighed on the...